Calyxt Reports Fourth Quarter 2022 Financial Results and Pro

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter...

Related Keywords

Minnesota , United States , California , Roseville , San Diego , Rory Riggs , Michaela Carr , Prnewswire Calyxt Inc , Calyxt Inc , Current Customer Projects Under Development , Nasdaq , Exchange Commission , Payroll Protection Program , Cibus Global , Cibus Inc , Evologic Technologies , Plant Cell Matrix , Chief Executive Officer , Nasdaq Capital Market , Chief Executive , Registration Statement , Customer Projects Under Development , Global Infrastructure Partner , Enable Growth , Proprietary Plant Cell Matrix , Evologic Technologies Gmbh , Three Months Ended December , Merger Agreement , Securities Litigation Reform Act , Annual Report , Ridge Road , Except Par Value , Share Amounts , Thousands Except Shares , Per Share Amounts , Calyxt , Nc ,